CA2285685A1 - Inhibiteurs selectifs du facteur xa - Google Patents

Inhibiteurs selectifs du facteur xa Download PDF

Info

Publication number
CA2285685A1
CA2285685A1 CA002285685A CA2285685A CA2285685A1 CA 2285685 A1 CA2285685 A1 CA 2285685A1 CA 002285685 A CA002285685 A CA 002285685A CA 2285685 A CA2285685 A CA 2285685A CA 2285685 A1 CA2285685 A1 CA 2285685A1
Authority
CA
Canada
Prior art keywords
group
aryl
6alkyl
integer
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285685A
Other languages
English (en)
Inventor
Bing-Yan Zhu
Robert M. Scarborough
Ting Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2285685A1 publication Critical patent/CA2285685A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des composés, ainsi que certains de leurs sels et certaines de leurs compositions, qui présentent une activité dirigée contre le facteur Xa des mammifères. Ces composés conviennent, in vitro ou in vivo, pour la prévention ou le traitement des troubles de la coagulation.
CA002285685A 1997-04-14 1998-04-13 Inhibiteurs selectifs du facteur xa Abandoned CA2285685A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6932297P 1997-04-14 1997-04-14
US60/069,322 1997-04-14
PCT/US1998/007159 WO1998046626A1 (fr) 1997-04-14 1998-04-13 INHIBITEURS SELECTIFS DU FACTEUR Xa

Publications (1)

Publication Number Publication Date
CA2285685A1 true CA2285685A1 (fr) 1998-10-22

Family

ID=22088205

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285685A Abandoned CA2285685A1 (fr) 1997-04-14 1998-04-13 Inhibiteurs selectifs du facteur xa

Country Status (7)

Country Link
US (1) US6204268B1 (fr)
EP (1) EP0977772A1 (fr)
JP (1) JP2001523226A (fr)
AU (1) AU6896298A (fr)
CA (1) CA2285685A1 (fr)
NZ (1) NZ500353A (fr)
WO (1) WO1998046626A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291892A (zh) 1998-01-27 2001-04-18 阿温蒂斯药物制品公司 取代的氧代氮杂杂环基因子Xa抑制剂
ATE307111T1 (de) * 1999-01-13 2005-11-15 Genentech Inc Serinprotease-inhibitoren
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6645520B2 (en) 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US6562370B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
PE20020420A1 (es) 2000-10-02 2002-06-27 Novartis Ag Derivados de diazacicloalcanodiona como antagonistas del antigeno asociado a la funcion del linfocito-1 (lfa-1)
GB0119797D0 (en) 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
PE20040167A1 (es) 2002-03-28 2004-05-26 Novartis Ag Amidas del acido sulfamico
EP2982668A3 (fr) 2002-12-03 2016-04-13 Pharmacyclics LLC Dérivés de 2-(2-hydroxybiphényl-3-yl)-1h-benzoimidazole-5-carboxamidine en tant qu'inhibiteurs du facteur viia inhibitors pour le traitement de maladies thromboemboliques
US20060178370A1 (en) * 2003-03-18 2006-08-10 Mark Bock Ketopiperazine derivatives as bradykinin antagonists
JP2007505160A (ja) 2003-05-20 2007-03-08 ジェネンテック・インコーポレーテッド 第ＶＩＩａ因子のアシルスルファミド阻害剤
AU2004249671A1 (en) 2003-05-20 2004-12-29 Genentech, Inc. Benzofuran inhibitors of factor VIIa

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143882A (fr) 1966-06-21
BE783499A (fr) 1971-05-28 1972-11-16 Delalande Sa N-tertiaire aminomethyl-4' dibenzo (b,e) oxepine-11-spiro- 2'-dioxolanne-1',3', leur procede de preparation et leur application en therapeutique
US4178438A (en) 1975-11-14 1979-12-11 Ciba-Geigy Aktiengesellschaft Cationically modified, cellulose-containing materials
JPS5334735A (en) 1976-09-07 1978-03-31 Sato Pharma Alphaannsubstitutedd*2**3**4** trimethoxybenzyl*acetamide and its salt*and process for producing these compounds
US4251438A (en) 1979-06-14 1981-02-17 The Upjohn Company Piperazinone and piperazine polypeptides
US4341698A (en) 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
JPS5896075A (ja) 1981-12-03 1983-06-07 Hokuriku Seiyaku Co Ltd １−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体
JPS58194873A (ja) 1982-05-11 1983-11-12 Hokuriku Seiyaku Co Ltd １−（３，４，５−トリメトキシシンナモイル）−４−アミノカルボニルメチル置換ピペラジン誘導体
JPS58216170A (ja) 1982-06-09 1983-12-15 Hokuriku Seiyaku Co Ltd １−（２，３，４−トリメトキシシンナモイル）−４−アミノカルボニルアルキル置換ピペラジン及びホモピペラジン誘導体、及びその製造方法
US4588587A (en) 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
CA1332410C (fr) 1984-06-26 1994-10-11 Roger M. Freidinger Analogues de benzodiazepines
WO1986003203A1 (fr) 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2595695B1 (fr) 1986-03-12 1988-12-02 Synthelabo Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
US5028610A (en) 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
GB8809316D0 (en) 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
IL86856A0 (en) 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
JPH0283375A (ja) 1988-09-21 1990-03-23 Dainippon Pharmaceut Co Ltd ２−置換ピペラジニル−２−（１，２−ベンズイソキサゾール−３−イル）酢酸誘導体
US5164388A (en) 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
IL92011A0 (en) 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
DE3928183A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
JPH03148223A (ja) 1989-11-02 1991-06-25 Otsuka Pharmaceut Co Ltd 血小板凝集抑制剤
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9017694D0 (en) 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
US5443815A (en) 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5521179A (en) 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
HUT68769A (en) 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
US5120718A (en) 1991-06-13 1992-06-09 Abbott Laboratories Candida acid protease inhibiting compounds
PL294870A1 (fr) 1991-06-21 1993-02-08 Hoechst Ag
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
AU646966B2 (en) 1991-08-23 1994-03-10 Takeda Chemical Industries Ltd. 2-piperazinone compounds, their production and use
FR2682381B1 (fr) 1991-10-10 1995-04-07 Rhone Poulenc Rorer Sa Derives de benzodiazepine, leur preparation et les medicaments les contenant.
DE69221309T2 (de) 1991-10-11 1997-12-11 The Du Pont Merck Pharmaceutical Co., Wilmington, Del. Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer
EP0610432A1 (fr) * 1991-10-31 1994-08-17 Smithkline Beecham Corporation Agents peptidomimetiques cycliques en c8 utilises comme antagonistes de fibrinogene
DE69321344D1 (de) 1992-02-14 1998-11-05 Corvas Int Inc Inhibitoren der thrombose
JP3060343B2 (ja) 1992-02-28 2000-07-10 コニカ株式会社 ハロゲン化銀カラー写真感光材料
EP0636144A1 (fr) 1992-04-16 1995-02-01 Zeneca Limited Peptides d'acide alpha-aminoboronique et leur utilisation comme inhibiteurs d'elastase
US5371072A (en) 1992-10-16 1994-12-06 Corvas International, Inc. Asp-Pro-Arg α-keto-amide enzyme inhibitors
US5583146A (en) 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
GB9225492D0 (en) 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
WO1994013693A1 (fr) 1992-12-15 1994-06-23 Corvas International, Inc. NOUVEAUX INHIBITEURS DU FACTEUR Xa
WO1994017817A1 (fr) 1993-02-12 1994-08-18 Corvas International, Inc. Inhibiteurs de la thrombose
US5656600A (en) 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
AU670381B2 (en) 1993-04-30 1996-07-11 Merck & Co., Inc. Thrombin inhibitors
JP3388803B2 (ja) 1993-05-20 2003-03-24 第一製薬株式会社 光学活性７−アミジノナフタレン誘導体の製造法
HUT70045A (en) 1993-06-17 1995-09-28 Takeda Chemical Industries Ltd 2-piperazinone derivatives parmaceutical compositions containing them and process for producing them
ES2132401T3 (es) 1993-07-26 1999-08-16 Pfizer Tetrahidro-1h-benzazepinonas y hexahidroazepinonas como antagonistas selectivos del receptor colecistoquinina-b.
US5430043A (en) 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
GB2287027A (en) 1994-03-04 1995-09-06 Lilly Co Eli Tripeptide antithrombotic agents
US5580979A (en) 1994-03-15 1996-12-03 Trustees Of Tufts University Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
EP0755394A1 (fr) 1994-04-15 1997-01-29 Glaxo Wellcome Inc. Procede d'induction d'une activite agoniste de la cholecystokinine a l'aide de composes 1,4-benzodiazepines
US5681844A (en) 1994-04-18 1997-10-28 Corvas International, Inc. Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
DE69532754T2 (de) 1994-04-26 2005-03-10 Aventis Pharmaceuticals, Inc. Faktor xa inhibitoren
JPH10503176A (ja) 1994-06-17 1998-03-24 コーバス インターナショナル， インコーポレイテッド 酵素インヒビターとしての３−アミノ−２−オキソ−１−ピペリジン酢酸誘導体
US5637599A (en) 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
US5703208A (en) 1994-06-17 1997-12-30 Corvas International, Inc. 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
US5714499A (en) 1994-06-17 1998-02-03 Corvas International, Inc. 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
US5932733A (en) * 1994-06-17 1999-08-03 Corvas International, Inc. 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
US5716929A (en) 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
FR2721611B1 (fr) 1994-06-22 1996-09-27 Adir Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
DE4423444A1 (de) 1994-07-05 1996-01-11 Bayer Ag Verfahren zur Herstellung von farbigen nativen oder synthetischen Substraten
MX9704439A (es) 1994-12-13 1997-10-31 Corvas Int Inc Derivados heterociclicos aromaticos como inhibidores de enzima.
US6025472A (en) 1994-12-21 2000-02-15 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
AU4250896A (en) 1994-12-22 1996-07-10 Biochem Pharma Inc. Heterocyclic keto arginine peptides as thrombin inhibitors
EP0802916A1 (fr) 1994-12-22 1997-10-29 Biochem Pharma Inc Inhibiteurs de la thrombine bicyclique a faible poids moleculaire
JPH10513462A (ja) 1995-02-10 1998-12-22 ビーエーエスエフ アクチェンゲゼルシャフト トロンビンインヒビター
AU698911B2 (en) 1995-04-04 1998-11-12 Merck & Co., Inc. Thrombin inhibitors
US5565568A (en) 1995-04-06 1996-10-15 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
DE19519245C2 (de) 1995-04-14 2003-04-30 Boehringer Ingelheim Kg Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5948785A (en) 1995-04-27 1999-09-07 The Green Cross Corporation Heterocyclic amide compounds and pharmaceutical use of the same
US5612363A (en) 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US5726171A (en) 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5721214A (en) 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US5523308A (en) 1995-06-07 1996-06-04 Costanzo; Michael J. Peptidyl heterocycles useful in the treatment of thrombin related disorders
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
WO1997001338A1 (fr) 1995-06-27 1997-01-16 Merck & Co., Inc. Inhibiteurs de la thrombine a base de pyridinone
IT1277405B1 (it) 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
WO1997006803A1 (fr) 1995-08-21 1997-02-27 Eli Lilly And Company 2-acylaminopropanamides en tant que secretagogues d'hormones de croissance
WO1997014417A1 (fr) 1995-10-19 1997-04-24 Merck & Co., Inc. Antagonistes du recepteur de fibrinogene
IL119466A (en) 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
US6034067A (en) 1996-02-13 2000-03-07 Akzo Nobel, N.V. Serine protease inhibitors
US5668289A (en) 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5632898A (en) 1996-08-13 1997-05-27 Isis Pharmaceuticals, Inc. Method for removing unreacted electrophiles from a reaction mixture
AU4172397A (en) 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
CA2268281A1 (fr) 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Inhibiteurs competitifs du facteur xa
AU743735B2 (en) 1996-10-11 2002-02-07 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
JP2001512742A (ja) 1997-08-11 2001-08-28 シーオーアール セラピューティクス インコーポレイテッド 選択的Ｘａ因子阻害剤
JP2001515842A (ja) 1997-08-11 2001-09-25 シーオーアール セラピューティクス インコーポレイテッド 選択的Ｘａ因子阻害剤

Also Published As

Publication number Publication date
NZ500353A (en) 2002-02-01
WO1998046626A1 (fr) 1998-10-22
JP2001523226A (ja) 2001-11-20
AU6896298A (en) 1998-11-11
US6204268B1 (en) 2001-03-20
EP0977772A1 (fr) 2000-02-09

Similar Documents

Publication Publication Date Title
CA2268381A1 (fr) Inhibiteurs selectifs du facteur xa
EP0937073A2 (fr) Inhibiteurs competitifs du facteur xa
EP0994892A1 (fr) INHIBITEURS SELECTIFS DU FACTEUR Xa
US6204268B1 (en) Selective factor Xa inhibitors
AU4904797A (en) Selective factor xa inhibitors
US6262047B1 (en) Selective factor Xa inhibitors
EP0994893B1 (fr) INHIBITEURS SELECTIFS DU FACTEUR Xa CONTENANT UNE STRUCTURE D'AZEPINONE CONDENSEE
AU741099B2 (en) Selective factor Xa inhibitors
US6369063B1 (en) Selective factor Xa inhibitors
US6063794A (en) Selective factor Xa inhibitors
US6333321B1 (en) Selective factor Xa inhibitors
US6228854B1 (en) Selective factor Xa inhibitors
US6369080B2 (en) Selective factor Xa inhibitors
US6194435B1 (en) Lactams as selective factor Xa inhibitors
WO1998016524A1 (fr) DERIVES HETEROCYCLIQUES UTILISES COMME INHIBITEURS DE FACTEUR Xa
US6218382B1 (en) Selective factor Xa inhibitors
AU743614B2 (en) Heterocyclic derivatives as factor Xa inhibitors
AU720513C (en) Selective factor Xa inhibitors
AU746471B2 (en) Selective factor Xa inhibitors containing a fused azepinone structure
AU8700598A (en) Selective factor xa inhibitors
AU8827098A (en) Selective factor xa inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued